Ad is loading...
DGLCX
Price
$20.37
Change
-$0.32 (-1.55%)
Updated
Nov 15 closing price
RNPGX
Price
$64.77
Change
-$0.94 (-1.43%)
Updated
Nov 15 closing price
Ad is loading...

DGLCX vs RNPGX

Header iconDGLCX vs RNPGX Comparison
Open Charts DGLCX vs RNPGXBanner chart's image
BNY Mellon Global Stock - C
Price$20.37
Change-$0.32 (-1.55%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R6
Price$64.77
Change-$0.94 (-1.43%)
VolumeN/A
CapitalizationN/A
DGLCX vs RNPGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DGLCX vs. RNPGX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGLCX is a StrongBuy and RNPGX is a StrongSell.

FUNDAMENTALS
Fundamentals
RNPGX has more cash in the bank: 142B vs. DGLCX (941M). RNPGX pays higher dividends than DGLCX: RNPGX (1.11) vs DGLCX (0.00). DGLCX was incepted earlier than RNPGX: DGLCX (18 years) vs RNPGX (16 years). RNPGX is a more actively managed with annual turnover of: 17.00 vs. DGLCX (10.12). RNPGX has a lower initial minimum investment than DGLCX: RNPGX (250) vs DGLCX (1000). RNPGX annual gain was more profitable for investors over the last year : 18.52 vs. DGLCX (-3.09). RNPGX return over 5 years is better than : 40.54 vs. DGLCX (-7.91).
DGLCXRNPGXDGLCX / RNPGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years16 years-
Gain YTD8.81415.80556%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets941M142B1%
Annual Yield % from dividends0.001.11-
Returns for 1 year-3.0918.52-17%
Returns for 3 years-28.48-9.39303%
Returns for 5 years-7.9140.54-20%
Returns for 10 years11.0769.7416%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLDI2.190.18
+8.96%
Calidi Biotherapeutics
EIX83.681.55
+1.89%
Edison International
ECPG49.220.83
+1.72%
Encore Capital Group
HWC58.45-0.96
-1.62%
Hancock Whitney Corp
ZNTL3.47-0.48
-12.15%
Zentalis Pharmaceuticals